MS
Meiji Seika Pharma Co., Ltd. disclosed a 7.9% stake in ARCT
Meiji Seika Pharma Co., Ltd. reported owning 7.9% of Arcturus Therapeutics Holdings Inc. (ARCT) (2,466,395 shares) in a Schedule 13G filed Nov 18, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 18, 2026
- Source
- Schedule 13G